Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vortioxetine for the Treatment of Hoarding Disorder- an Open Label Study

NCT04035850 is registered in ClinicalTrials.gov with Noam Soreni as lead sponsor.

NCT NCT04035850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04035850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vortioxetine for the Treatment of Hoarding Disorder- an Open Label Study
Lead sponsor
Noam Soreni
Phase
Phase 3
Overall status
Withdrawn
Start date
August 1, 2019
Completion date
August 1, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hoarding disorder